At the IGTP TODAY
The demonstration of the vaccine's efficacy in its preclinical phase was carried out at the Comparative Medicine and Bioimage Centre of Catalonia, a trategic project of IGTP.
A clinical trial involving 40 patients, led by IrsiCaixa and IGTP and conducted at HUGTiP, confirms that the RUTI® vaccine, owned by Archivel Farma, enhances the effectiveness of the current treatment for non-muscle-invasive bladder cancer.
A study led by GCAT-IGTP links the VEGFA protein to long COVID, especially in postmenopausal women, suggesting a vascular mechanism behind persistent symptoms. The findings highlight the need to consider sex and hormonal status in long COVID research and treatment.
CEEISCAT and the Grupo de Trabajo sobre Tratamientos del VIH (gTt-VIH) announce the start of data collection for the SEXPROM Study, a pioneering investigation in Spain that will explore sexual satisfaction among people living with HIV, with a differentiated focus by gender and sexual orientation.
The combination of the drug nivolumab with chemotherapy improves survival in patients with high-risk head and neck cancer and could become the new standard treatment, according to the results of an international trial led by professionals from ICO, IGTP and IDIBELL.
A study coordinated from Badalona by IrsiCaixa, the Catalan Institute of Oncology and the Germans Trias i Pujol Research Institute (within the CARE programme) has identified KIMA, a genomic signature that makes it possible to anticipate which patients with HR+/HER2- breast cancer will respond less well to CDK4/6 inhibitors. The finding, published in the journal Clinical and Translational Medicine, may help personalize therapies and design new combinations.
The Department of Equality and Feminisms of the Government of Catalonia has granted funding to a research project addressing gender inequalities and the health of women in vulnerable situations. The study is led by CEEISCAT, a research group of the IGTP.
_1757327026.png)
The iCor team at the Germans Trias i Pujol University Hospital and Research Institute is the first in Spain to enrol a patient in the international EASY-AS study, a clinical trial to evaluate whether intervening before the first symptoms of severe aortic stenosis appear can improve clinical outcomes.
The study provides a comprehensive analysis of 3D techniques to generate multicellular tumor spheroids of colorectal cancer.
On the occasion of World Hepatitis Day, IGTP presents the results of the HepBClink project, which has combined community educational actions on hepatitis B and C with screening and referral to treatment for migrants from Pakistan, Senegal and Romania. The project has involved the participation of the DxEpiPath group at IGTP and is part of the Tranversal Program CORE.
